Burden of Tricuspid Regurgitation in Patients Undergoing Coronary Artery Bypass Grafting

Nathan Haywood1, J Hunter Mehaffey1, W Zachary Chancellor1

  • 1Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.

Insights

Tricuspid regurgitation (TR) increases surgical risk and adverse outcomes in patients undergoing coronary artery bypass graft (CABG) surgery. This study suggests considering tricuspid intervention during CABG for patients with significant TR.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Outcomes

Background:

  • Tricuspid regurgitation (TR) is linked to adverse outcomes post cardiac surgery.
  • Current guidelines do not mandate TR correction during coronary artery bypass graft (CABG) surgery.

Purpose of the Study:

  • To evaluate the impact of tricuspid regurgitation severity on outcomes following CABG surgery.
  • To assess if TR severity influences major morbidity or mortality in CABG patients.

Main Methods:

  • Analysis of 28,027 patients undergoing CABG from 2011-2018 using The Society of Thoracic Surgeons (STS) database.
  • Stratification of patients by tricuspid regurgitation severity (mild, moderate, severe).
  • Comparison of primary outcomes including major morbidity and mortality using univariate analysis and risk adjustment.

Main Results:

  • 17% had mild, 3% moderate, and 0.29% severe TR.
  • Higher TR severity correlated with increased preoperative heart failure and STS predicted risk of mortality.
  • Increasing TR severity was associated with higher rates of postoperative renal failure, prolonged ventilation, and mortality (all P < .001).
  • Mild, moderate, and severe TR remained independently associated with increased morbidity and mortality after risk adjustment (all P < .05).

Conclusions:

  • Tricuspid regurgitation severity independently increases surgical risk in CABG patients, beyond STS risk calculator predictions.
  • These findings underscore the importance of TR in operative risk assessment.
  • Concurrent tricuspid intervention should be considered for patients with significant TR undergoing CABG.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
261
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
278
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
317
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
262
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
203
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
187